NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
SCGSucroferric oxyhydroxide 500mg chewable tablets Velphoro® Nutrition and blood, Phosphate-binding agents, 09.05.02.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Calcium  Calcium Acetate Nutrition And Metabolic Disorders, Electrolytes And Minerals, Calcium
Fluid And Electrolyte Imbalances, Phosphate Imbalance, Hyperphosphataemia
Calcium  Calcium Acetate With Magnesium Carbonate Nutrition And Metabolic Disorders, Phosphate Binders
Fluid And Electrolyte Imbalances, Phosphate Imbalance, Hyperphosphataemia
Lanthanum Lanthanum Nutrition And Metabolic Disorders, Phosphate Binders
Fluid And Electrolyte Imbalances, Phosphate Imbalance, Hyperphosphataemia
Sevelamer  Sevelamer Nutrition And Metabolic Disorders, Phosphate Binders
Fluid And Electrolyte Imbalances, Phosphate Imbalance, Hyperphosphataemia
Sucroferric  Sucroferric Oxyhydroxide Nutrition And Metabolic Disorders, Phosphate Binders
Fluid And Electrolyte Imbalances, Phosphate Imbalance, Hyperphosphataemia
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
BLMK ICB ratified: East & North Herts NHS Trust Shared Care Guideline for the Use of Oral Lanthanum for Hyperphosphataemia in Adult Patients with Chronic Kidney Disease
BLMK ICB ratified: East & North Herts NHS Trust Shared Care Guideline for the Use of Oral Sevelamer for Hyperphosphataemia in Adult Patients with Chronic Kidney Disease
BLMK ICB ratified: East & North Herts NHS Trust Shared Care Guideline for the Use of Oral Sevelamer for Hyperphosphataemia in Adult Patients with Chronic Kidney Disease
BLMK ICB ratified: Sucroferric oxyhydroxide (oral) for hyperphosphataemia in adult patients with end stage renal failure requiring renal replacement therapy
NICE CG157: Hyperphosphataemia in chronic kidney disease 2013